IN2014CH00984A - - Google Patents

Download PDF

Info

Publication number
IN2014CH00984A
IN2014CH00984A IN984CH2014A IN2014CH00984A IN 2014CH00984 A IN2014CH00984 A IN 2014CH00984A IN 984CH2014 A IN984CH2014 A IN 984CH2014A IN 2014CH00984 A IN2014CH00984 A IN 2014CH00984A
Authority
IN
India
Prior art keywords
pharmaceutical composition
preparing
processes
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Alluri Pavan
Prakash Uppala Susheel
Thummisetty Mastanaiah
Kandarapu Raghupathi
S Rudraraju Varma
Original Assignee
Aizant Drug Res Solutions Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aizant Drug Res Solutions Private Ltd filed Critical Aizant Drug Res Solutions Private Ltd
Priority to IN984CH2014 priority Critical patent/IN2014CH00984A/en
Publication of IN2014CH00984A publication Critical patent/IN2014CH00984A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN984CH2014 2014-02-27 2014-02-27 IN2014CH00984A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN984CH2014 IN2014CH00984A (pt) 2014-02-27 2014-02-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN984CH2014 IN2014CH00984A (pt) 2014-02-27 2014-02-27

Publications (1)

Publication Number Publication Date
IN2014CH00984A true IN2014CH00984A (pt) 2015-08-28

Family

ID=54395117

Family Applications (1)

Application Number Title Priority Date Filing Date
IN984CH2014 IN2014CH00984A (pt) 2014-02-27 2014-02-27

Country Status (1)

Country Link
IN (1) IN2014CH00984A (pt)

Similar Documents

Publication Publication Date Title
PH12020551089A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
PH12018500975A1 (en) 7-(thiazol-5-yl) pyrrolopyrimidine compound as tlr7 agonist
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
MX2017016802A (es) Formulaciones farmaceuticas.
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12017502376B1 (en) Oral solid formulation containing irinotecan and method of preparing the same
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2017009289A (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
MX2014013664A (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxietil)ami no)-2-oxo-n-fenil-1,2-dihidroquinolin-3-carboxamida.
MX2019008338A (es) Composicion farmaceutica que contiene sulglicotido o una sal farmaceuticamente aceptable del mismo para la prevencion o tratamiento del ojo seco.
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
IN2014CH00984A (pt)
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
MX2015017124A (es) Combinacion de ro5503781, capecitabina y oxaliplatino para la terapia para el cancer.
PH12018500946A1 (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
TR201819312A2 (tr) Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu
AU2017900496A0 (en) Compounds for Enhancing the Permeation of Active Pharmaceutical Ingredients through Skin
GR1008380B (el) Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου
IN2013CH01615A (pt)
IN2014MU01179A (pt)